Chronic Lymphocytic Leukemia
The Pharmacy Times® Chronic Lymphocytic Leukemia Resource Center is a comprehensive resource for clinical news and expert insights on treatments for chronic lymphocytic leukemia.
Latest News
August 7th 2025
Birelentinib gains FDA fast track designation, offering hope for relapsed CLL/SLL patients resistant to current BTK and BCL2 therapies.
More News
Safety, Efficacy of BOVen Therapy in Patients With Previously Untreated CLL
December 22nd 2021Jacob D. Soumerai, MD, of Harvard Medical School and Massachusetts General Hospital, discusses trial results showing the safety and efficacy of zanubrutinib, obinutuzumab, and venetoclax in the treatment of previously untreated chronic lymphocytic leukemia.
Watch
Assessing Adverse Events From BOVen Therapy in Patients With Previously Untreated CLL
December 21st 2021Jacob D. Soumerai, MD, of Harvard Medical School and Massachusetts General Hospital, discusses the adverse events experienced by patients with previously untreated chronic lymphocytic leukemia when treated with zanubrutinib, obinutuzumab, and venetoclax.
Watch
